Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resis
about
Efficacy of ceftazidime-avibactam in a rat intra-abdominal abscess model against a ceftazidime- and meropenem-resistant isolate of Klebsiella pneumoniae carrying blaKPC-2.In Vitro Activity of Ceftazidime-Avibactam Against Isolates from Patients in a Phase 3 Clinical Trial for the Treatment of Complicated Intra-Abdominal Infections.Assessment of Ceftazidime-Avibactam 30/20 μg Disk Content Versus MIC Results When Tested against Enterobacteriaceae and Pseudomonas aeruginosa.
P2860
Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resis
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Molecular β-Lactamase Characte ...... against Susceptible and Resis
@en
type
label
Molecular β-Lactamase Characte ...... against Susceptible and Resis
@en
prefLabel
Molecular β-Lactamase Characte ...... against Susceptible and Resis
@en
P2093
P2860
P50
P356
P1476
Molecular β-Lactamase Characte ...... against Susceptible and Resis
@en
P2093
Gregory G Stone
Leah N Woosley
Rodrigo E Mendes
P2860
P356
10.1128/AAC.02447-16
P407
P577
2017-03-27T00:00:00Z